Studies of human pancreatic elastase treatment of rabbit and human vein rings to predict human therapeutic doses.

Burke, Steven K; Bunton, David; Bingham, Karen; Moss, Emma; Bland, Kimberly S; Starcher, Barry; Wong, Marco D; Franano, F Nicholas

Burke, Steven K; Bunton, David; Bingham, Karen; Moss, Emma; Bland, Kimberly S; Starcher, Barry; Wong, Marco D; Franano, F Nicholas.

Afiliación

Burke SK; Proteon Therapeutics Waltham Massachusetts.
Bunton D; Biopta, Ltd. Glasgow United Kingdom.
Bingham K; Biopta, Ltd. Glasgow United Kingdom.
Moss E; Biopta, Ltd. Glasgow United Kingdom.
Bland KS; Proteon Therapeutics Waltham Massachusetts; Present address: Stowers Institute for Medical Research Kansas City MO.
Starcher B; The University of Texas Health Science Center Tyler Texas.
Wong MD; Proteon Therapeutics Waltham Massachusetts.
Franano FN; Proteon Therapeutics Waltham Massachusetts; Present address: Flow Forward Medical Olathe KS.

Pharmacol Res Perspect ; 4(3): e00229, 2016 06.

Article en En | MEDLINE | ID: mdl-27433340

Palabras clave

CELA1; PRT201; chymotrypsinlike elastase family member 1; elastase; elastin; hemodialysis access; vein; vonapanitase

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmacol Res Perspect Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google